📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. (2022)

First Author: Duthie MS

Attributed to: Development of a human challenge model of Leishmania major infection as a tool for assessing vaccines against leishmaniasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pathogens11111259

PubMed Identifier: 36365010

Publication URI: http://europepmc.org/abstract/MED/36365010

Type: Journal Article/Review

Volume: 11

Parent Publication: Pathogens (Basel, Switzerland)

Issue: 11

ISSN: 2076-0817